Cargando…
Outcomes in growth hormone-treated Noonan syndrome children: impact of PTPN11 mutation status
INTRODUCTION: Mutations in PTPN11 are associated with Noonan syndrome (NS). Although the effectiveness of growth hormone therapy (GHT) in treating short stature due to NS has been previously demonstrated, the effect of PTPN11 mutation status on the long-term outcomes of GHT remains to be elucidated....
Autores principales: | Jorge, Alexander A L, Edouard, Thomas, Maghnie, Mohamad, Pietropoli, Alberto, Kelepouris, Nicky, Romano, Alicia, Zenker, Martin, Horikawa, Reiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9066595/ https://www.ncbi.nlm.nih.gov/pubmed/35245205 http://dx.doi.org/10.1530/EC-21-0615 |
Ejemplares similares
-
Cardiovascular safety of growth hormone treatment in Noonan syndrome: real-world evidence
por: Romano, Alicia, et al.
Publicado: (2021) -
Noonan syndrome: rhGH treatment and
PTPN11
mutation
por: Wu, Xian, et al.
Publicado: (2023) -
Response to growth hormone therapy in children with Noonan syndrome: correlation with or without PTPN11 Gene mutation
por: Kim, Yoo-Mi, et al.
Publicado: (2013) -
Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation
por: Jongmans, Marjolijn C J, et al.
Publicado: (2011) -
KRAS Analysis in 34 Noonan Syndrome Patients without
PTPN11 Mutation
por: Yamamoto, Kaoru, et al.
Publicado: (2007)